IL1B and Alzheimer disease: The NLRP3 inflammasome, first described in 2002 [22,23], is involved in the activation of caspase-1, leading to the release of IL-18 and IL-1β and resulting in a strong inflammatory response that has been observed in multiple diseases, including AD [24].